{{Rsnum
|rsid=17024926
|Gene=NPAS2
|Chromosome=2
|position=100889540
|Orientation=plus
|GMAF=0.3737
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NPAS2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 11.5 | 43.4 | 45.1
| HCB | 28.5 | 48.9 | 22.6
| JPT | 23.9 | 46.9 | 29.2
| YRI | 6.1 | 42.2 | 51.7
| ASW | 12.3 | 26.3 | 61.4
| CHB | 28.5 | 48.9 | 22.6
| CHD | 31.2 | 48.6 | 20.2
| GIH | 6.9 | 32.7 | 60.4
| LWK | 8.2 | 41.8 | 50.0
| MEX | 12.1 | 43.1 | 44.8
| MKK | 7.1 | 31.4 | 61.5
| TSI | 6.9 | 43.1 | 50.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19934327
|Title=Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=23822714
|Title=Analysis of polymorphisms in the circadian-related genes and breast cancer risk in the Norwegian nurses working night shifts
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}